Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled “Recall fallout: FDA puts execs on notice.” Rosen discusses increased efforts by the Food and Drug Administration to identify and potentially prosecute executives at companies that have issued a number of recalls due to manufacturing violations. He states that the FDA is developing a tougher compliance attitude because companies are ignoring warnings from the agency, adding that it appears the FDA wants to send a clearer message regarding regulation and compliance.
People
Related News
July 7, 2025
In the News
Louis Lehot Assesses Deal Trends in Shifting Market
Foley & Lardner LLP partner Louis Lehot assessed dealmaking trends in the Law360 article, "PE Dealmakers Best-Suited To Cut Through M&A Challenges."
July 3, 2025
In the News
Christopher Swift Assesses CFIUS Involvement in Telecommunications Acquisition
Foley & Lardner LLP partner Christopher Swift shared insight on the Committe on Foreign Investment in the United States’ (CFIUS) involvement in a telecommunications transaction in The Capitol Forum article, “T-Mobile/UScellular: Team Telecom’s Deference Gives DOJ, FCC Flexibility to Penalize Buyer If It Violates Agreement.”
July 3, 2025
In the News
Louis Lehot Highlights Opportunities and Challenges for M&A Market
Foley & Lardner LLP partner Louis Lehot highlighted opportunities and challenges for the M&A market in the Law360 article, "Mid-Year M&A Deal Flow Suffers Amid Global Instability."